Medicare Enrolled

Dr. Abdul Khan, M.D.

Internal Medicine · Manteca, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1144 NORMAN DR, Manteca, CA 95336
2098241230
In practice since 2005 (20 years)
NPI: 1053399980 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khan

Dr. Abdul Khan is an internal medicine specialist in Manteca, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 1,855 Medicare services across 1,272 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khan received a total of $15,515 from 76 pharmaceutical and/or device companies across 999 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in CA $15,515 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,855
Medicare services
Top 18% in CA for internal medicine
1,272
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~93 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
602 $56 $155
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
266 $84 $230
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
250 $135 $255
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
237 $77 $170
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
141 $11 $45
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
89 $32 $40
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
88 $72 $125
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
80 $1 $15
Annual wellness visit, initial visit
A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment.
37 $172 $365
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
36 $1 $15
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $87 $345
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
14 $11 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,515
Total received (2018-2024)
Avg $2,216/year across 7 years
Top 7% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
999
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,452 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$62 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,827
2023
$1,994
2022
$2,602
2021
$2,885
2020
$2,415
2019
$1,701
2018
$2,090

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$344
AstraZeneca Pharmaceuticals LP
$260
Novo Nordisk Inc
$186
GlaxoSmithKline, LLC.
$150
Axsome Therapeutics, Inc.
$146
Lilly USA, LLC
$137
PFIZER INC.
$102
IDORSIA PHARMACEUTICALS US INC
$56
Novartis Pharmaceuticals Corporation
$49
Verity Pharmaceuticals Inc.
$40
Esperion Therapeutics, Inc.
$38
Paratek Pharmaceuticals, Inc.
$36
Sumitomo Pharma America, Inc.
$29
IRONWOOD PHARMACEUTICALS, INC
$29
E.R. Squibb & Sons, L.L.C.
$28
Exact Sciences Corporation
$28
SANOFI PASTEUR INC.
$27
INTUITIVE SURGICAL, INC.
$26
Corcept Therapeutics
$24
Merck Sharp & Dohme LLC
$22
Collegium Pharmaceutical, Inc.
$20
Medtronic, Inc.
$17
Amgen Inc.
$16
Otsuka America Pharmaceutical, Inc.
$16
Top 3 companies account for 43.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,599
Novo Nordisk Inc
$1,245
GlaxoSmithKline, LLC.
$1,237
ABBVIE INC.
$904
Lilly USA, LLC
$875
PFIZER INC.
$707
Boehringer Ingelheim Pharmaceuticals, Inc.
$536
AbbVie Inc.
$528
Takeda Pharmaceuticals U.S.A., Inc.
$452
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$434
Amgen Inc.
$432
Kowa Pharmaceuticals America, Inc.
$417
Otsuka America Pharmaceutical, Inc.
$412
Janssen Pharmaceuticals, Inc
$277
Merck Sharp & Dohme Corporation
$257
Allergan, Inc.
$256
Axsome Therapeutics, Inc.
$249
SANOFI-AVENTIS U.S. LLC
$249
E.R. Squibb & Sons, L.L.C.
$225
Esperion Therapeutics, Inc.
$222
Allergan Inc.
$212
Sunovion Pharmaceuticals Inc.
$209
IDORSIA PHARMACEUTICALS US INC
$204
Amarin Pharma Inc.
$179
Teva Pharmaceuticals USA, Inc.
$176
Novartis Pharmaceuticals Corporation
$174
Daiichi Sankyo Inc.
$158
Eisai Inc.
$151
AbbVie, Inc.
$136
Hikma Pharmaceuticals USA
$128
Abbott Laboratories
$126
Biohaven Pharmaceuticals, Inc.
$124
Exact Sciences Corporation
$112
Collegium Pharmaceutical, Inc.
$110
Merck Sharp & Dohme LLC
$98
Medtronic, Inc.
$96
Biohaven Pharmaceutical Holding Company Ltd.
$87
Bausch Health US, LLC
$87
SANOFI PASTEUR INC.
$86
IRONWOOD PHARMACEUTICALS, INC
$83
Lundbeck LLC
$73
Ironwood Pharmaceuticals, Inc
$69
Mannkind Corporation
$65
Eyevance Pharmaceuticals LLC
$65
Sumitomo Pharma America, Inc.
$64
Boston Scientific Corporation
$62
Upsher-Smith Laboratories LLC
$59
Medicure Pharma Inc.
$51
Xeris Pharmaceuticals, Inc.
$49
Verity Pharmaceuticals Inc.
$40
Bayer Healthcare Pharmaceuticals Inc.
$40
MannKind Corporation
$38
Horizon Pharma plc
$38
Horizon Therapeutics plc
$37
Qiagen, LLC
$36
Paratek Pharmaceuticals, Inc.
$36
Astellas Pharma US Inc
$35
Bayer HealthCare Pharmaceuticals Inc.
$34
Lupin Inc.
$32
Alfasigma USA, Inc.
$32
ARBOR PHARMACEUTICALS, INC.
$29
INTUITIVE SURGICAL, INC.
$26
Corcept Therapeutics
$24
Tactile Systems Technology Inc
$24
Tris Pharma Inc
$23
ITI, Inc.
$23
AMAG Pharmaceuticals, Inc.
$22
Purdue Pharma L.P.
$22
EISAI INC.
$22
United Therapeutics Corporation
$19
Aytu BioScience, Inc
$17
Acerus Pharmaceuticals Corporation
$15
Mylan Specialty L.P.
$15
Seqirus USA Inc
$15
UPSHER-SMITH LABORATORIES LLC
$13
FORTE BIO-PHARMA LLC
$3
Top 3 companies account for 26.3% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADACEL · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · APTIOM · AREXVY · AUSTEDO · Aimovig · Amitiza · Androgel · Auvelity · BELSOMRA · BEXSERO · BREO · BREZTRI · BYSTOLIC · Belbuca · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CardioMEMS HF System · Cologuard Collection Kit · DUEXIS · DUZALLO · Da Vinci Surgical System · Dayvigo · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLEXITOUCH · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GEMTESA · GVOKE PFS · HMG-CoA reductase inhibitor. · INFINION · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INTRAROSA · JANUVIA · JARDIANCE · Kerendia · Kloxxado · Korlym · LATUDA · LEQVIO · LINZESS · LO LOESTRIN FE · LYRICA · Linzess · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYRBETRIQ · Mitigare · Motegrity · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · Natesto · OFEV · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROLATE · Prolia · QUANTIFERON-TB GOLD PLUS · QULIPTA · QUVIVIQ · QVAR · RELISTOR · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOLOSEC · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUPRAX · SYMBICORT · SYMPROIC · SYNTHROID · Saxenda · Synthroid · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TRUMENBA · TYVASO · Tlando · Tobradex ST · Tresiba · Trintellix · UBRELVY · Utibron · VRAYLAR · VYVANSE · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Yupelri · ZENPEP · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in CA.

Looking for an internal medicine specialist in Manteca?
Compare internal medicine physicians in the Manteca area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
405
Per 100K population
51.4
County median income
$88,531
Nearest hospital
DOCTORS HOSPITAL OF MANTECA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khan is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Khan performed 602 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $15,515 from 76 companies across 999 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other internal medicine physicians in Manteca?
Dr. Khan's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →